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The mammary gland contains adult stem cells that are capable of self-renewal and are likely target for
neoplastic transformation leading to breast cancer. In this study, we developed a cell culture derived
from the mammary glands of cynomolgus monkeys (Macaca fascicularis) (MfMC) and furthermore
identified the expression of markers for stemness and estrogen receptor-associated activities. We found
that the primary culture can be successfully subcultured to at least 3 passages, primarily epithelial-like in
morphology, the cultured cells remained heterogenous in phenotype as they expressed epithelial cell
markers CD24, CK18, and marker for fibroblast S1004A. Importantly, the cell population also consistently
expressed the markers of mammary stem cells (ITGB1 or CD29 and ITGA6 or CD49f), mesenchymal stem
cells (CD73 and CD105) and pluripotency (NANOG, OCT4, SOX2). In addition to this, the cells were also
positive for Estrogen Receptor (ER), and ER-activated marker Trefoil Factor 1, suggesting an estrogen
responsiveness of the culture model. These results indicate that our cell culture model is a reliable model
for acquiring a population of cells with mammary stem cell properties and that these cultures may also
serve as a reservoir from which more purified populations of stem cell populations can be isolated in the
future.
Copyright © 2017 Institut Pertanian Bogor. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Multipotent stem cells, known as adult stem cells, are essential
to the maintenance of most tissues in the body throughout life.
These cells have the ability to undergo self-renewal to produce two
stem cells or can divide in a fashion such that one cell remains a
stem cell, whereas the other daughter cell undergoes further dif-
ferentiation. Adult stem cells are normally only present in small
numbers within most tissues after gestational development.
Mammary gland development is unique, however, as full differ-
entiation of this organ is only attained at adulthood through
pregnancy and lactation (Liu et al. 2005). Consistent with this fact,
nulliparous breasts are known to contain large numbers of undif-
ferentiated stem cells (LaMarca and Rosen 2008; Stingl et al. 2006).).
nian Bogor.
r. Production and hosting by ElsAdult mammary glands consist of the lobular and ductal structures
composed of three cell lineages: alveolar epithelial cells that line
the alveoli and synthesize milk proteins; ductal epithelial cells that
line the lumen of the ducts; and myoepithelial cells that form the
basal layer of both the ducts and alveoli. Alveolar, ductal, and
myoepithelial components of the mammary gland initially origi-
nate from a common multipotent adult stem cell, the mammary
stem cell (MaSC; Shackleton et al. 2006). During its normal devel-
opmental cycle, the mammary gland shows many characteristics
similar to those previously associated with breast carcinogenesis
and it has therefore been concluded that factors implicating normal
mammary development are also important in breast carcinogen-
esis. In turn, it is likely that a better understanding of normal breast
developmentmay prove useful in elucidating how tumors originate
and thrive (Wiseman and Werb, 2002).
Breast cancer is proposed to originate primarily from the pop-
ulations of undifferentiated stem cells that residewithin the lobular
aspects of the breast. This hypothesis has been supported by
numerous studies including those investigating the vulnerability ofevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Mammary gland cell culture of Macaca fascicularis 137mammary cells to chemical-induced carcinogenesis (Russo et al.
2005; Eden 2010). Based on the stem cell theory of carcinogenesis,
the long-lived stem cells of the mammary gland have the potential
to be exposed to larger numbers of mutagenic events over their
lifetime than do the shorter-lived, more-differentiated cells of the
gland. The switch from normal development to carcinogenesis can
then either occur in the stem cells themselves as these cells acquire
multiple deleterious mutations over time, or cancerous cells can
arise from the progeny of these stem cells as they acquire additional
mutations and the ability to self-renew. In light of this information,
the purification and characterization of normalMaSCs is likely to be
extremely useful for understanding normal mammary develop-
ment, as well as carcinogenesis risk (Dontu et al. 2003b).
Difficulty in obtaining MaSCs for study of the adult MaSCs is due
in large part to the small numbers of cells typically foundwithin the
mammary gland, limited availability of markers for the character-
ization of MaSCs, and limited techniques to maintain the MaSCs in
an undifferentiated state. (Dontu et al. 2003a). MaSCs are likely to
be more abundant at specific life stages, such as during puberty or
in early adulthood before first pregnancy (i.e. nulliparity) when the
breasts are less differentiated (Meier-abt et al. 2013). Therefore,
choosing the right developmental stage is critical to ensure that
enough stem cells are present in the breast tissue to allow for
isolation and/or enrichment of these cells. As acquiring normal
breast tissue from the developmental stages of greatest interest to
stem cell researchers is restricted by ethical constraints in humans,
the use of nonhuman primate (NHP) models is likely to be useful in
by-passing such limitations. NHPs have similarities with humans in
genomics, anatomy, and physiology. Importantly, the cynomolgus
macaque (Macaca fascicularis) mammary gland has been demon-
strated to have high similarity with human breast with regard to
development, morphology, molecular profile, and carcinogenesis
(Cline and Wood 2008; Dewi et al. 2013; Dewi et al. 2016). There-
fore, the use of cynomolgus monkey-derived tissue and cells pro-
vides the benefit of studying breast development and breast cancer
risk at specific reproductive ages, including that involving estro-
genic exposure as well as stem cell regulation. Here, we developed
a cell culture model derived from the mammary gland of cyn-
omolgus monkeys or M. fascicularis, abbreviated as M. fascicularis
mammary cell culture (MfMC). This highly translational cell culture
model shall serve as a reservoir forMaSCs population, whichwill be
potential for further enrichment.
2. Material and Methods
2.1. Animals
We conducted breast biopsy on adult nulliparous M. fascicularis
(n ¼ 3; age 5e6 years) to collect mammary gland tissues. All pro-
cedures involving animals were performed at Research Animal
Facility-Lodaya, Primate Research Center at Bogor Agricultural Uni-
versity (PSSP-IPB), an AAALAC International-accredited facility,
following ethics approval from PSSP-IPB Institutional Animal Care
and Use Committee. Validation of menstrual cycle of monkeys at the
time of biopsy was performed by vaginal cytology, following daily
observation to identify menstrual bleeding pattern. This validation
was performed to identify the cycle stage of the animal (i.e. luteal
phase) because hormone profile during menstrual cycle influences
the expression of ER in the breast tissue (Stute et al., 2004; Stute
et al., 2012). Breast biopsy was performed on deeply-anesthetized
animals; under aseptic condition, subcutaneous tissue (approxi-
mately 2 cm  0.5 cm in size) that contains mammary glands were
collected. On removal, the tissues were placed in transport media
(Dulbecco’s Modified Eagle’s Medium, antibiotics, antifungal).
Intensive peri- and postoperative care were performed, wherebyanimals were given analgesics and antibiotics, and closely observed
throughout the week after biopsy.
2.2. Cell culture
Mammary tissues obtained from biopsy comprised adipose and
glandular tissues. The texture was relatively hard and therefore
difficult to dissociate. Digestion with the enzymes collagenase and
hyaluronidase allowed for easier mincing and disaggregation. Cells
dissociation were performed mechanically and enzymatically ac-
cording to the method previously described (Dey et al. 2009) with
slight modifications. The collected tissues were digested in 0.075%
collagenase (Sigma Aldrich, USA) and 1 mg hyaluronidase (Sigma
Aldrich, USA), and incubated in a humidified atmosphere at 37C,
5% CO2 for 16e18 hours. The tissues wereminced and centrifugated
at 500 g for 10 min. Supernatant was removed and resuspended in
10 mL phosphate-buffered saline twice. Cells were resuspended to
ensure single cells suspension was formed. Hemocytometer was
used to confirm the presence of single cells suspension; viable cells
were calculated using trypan blue. Cell suspension was plated at
appropriate density in selective medium for mammary epithelial
cells (Lonza, USA) and incubated in a humidified atmosphere at
37C, 5% CO2. Subculture was performed when cell population
reached 80% confluency. Human mammary epithelial cell culture
(MCF-12A ATCCR CRL 10782) was used as a comparison. Cells were
maintained with the same condition as MfMC.
2.3. Reverse transcription-polymerase chain reaction
RNA was extracted from cells using RNeasy Kit (Qiagen, Ger-
many), and reverse transcribed using SuperScript III Reverse Tran-
scriptase (Invitrogen, USA), according to the manufacturer's
instructions. Gene expression was evaluated using thermocycler
polymerase chain reaction; primers used for polymerase chain re-
action amplification are presented in Table 1.
3. Results
3.1. Cell morphology
Monkey breast-derived cells were cultured in selective medium
specific for mammary epithelial cells enrichment. Although the
morphology of MCF-12A in the same medium remained epithelial-
like throughout different passages, the MfMC cell population
grown showed predominant epithelial-like morphology alongside
fibroblast-like and adipocyte-like morphologies (Figure 1). The
MfMC culture was successfully subcultured up to three passages
with cell viability of 74%e88% (Figure 2).
3.2. Markers validation
MfMC cell population expressed the mRNA of epithelial cell
markers CD24 and CK18 on all passages (Figure 3). Despite the use
of medium selective for epithelial cells, expression of a stromal cell
marker S100A4 was also positive. This finding, however, was
somewhat consistent with that in MCF-12A, which is a human-
derived mammary epithelial cell culture model. In MCF-12A, the
stromal cell marker was also expressed, although in relatively
lower level compared with that in MfMC. Importantly, various
markers of stemness (Figure 4) and markers for pluripotency
(Figure 5) were expressed in MfMC throughout all passages, sug-
gesting the presence of stem cell populationwithin the culture. This
was also the case for MCF-12A.
3.3. Estrogen receptor markers
Markers for estrogen receptor (ER; ESR1) and ESR1-regulated
activity were evaluated in MfMC and MCF-12A. ESR1 was clearly
expressed, indicating that the cells are likely to be responsive to
Table 1. Primer sequences
Gene Sequence (50e30) References
Forward Reverse
CD24 CCCACGCAGATTTATTCCAG GACTTCCAGACGCCATTTG Modur et al. 2016
CK18 ATCTTGGTGATGCCTTGGAC CCTGCTTCTGCTGGCTTAAT Makino et al. 2009
ITGB1 GTTACACGGCTGCTGGTCTT CTACTGCTGACTTAGGGATC Qiu L et al. 2012
ITGA6 CAAGATGGCTACCCAGATAT CTGAATCTGAGAGGGAACCA Qiu L et al. 2012
CD73 GACCTGGCTTTGTGACAGCAA CTGACCCTGAGTAATCATGTCAGTCT Designed by Ricky Fong
CD105 GACTGTCTTCACGCGCTTGA GGAAGGCACCAAAGGTGATG Designed by Ricky Fong
NANOG CCAGTCCCAAAGGCAAACA TCTTGACCGGGACCTTGTCT Designed by Ricky Fong
OCT4 GATGTGGTCCGAGTGTGGTTCT GTTGTGCATAGTCACTGCTCGAT Designed by Ricky Fong
SOX2 CTAGAAACCCATTTATTCCCTGACA GACAACTCCTGATACTTTTTTGAACAA Designed by Ricky Fong
ESR1 GAGACATGAGAGCTGCCAAC ACCCTCTTTGCCCAGTTGAT Designed by Fitriya N. Dewi
GREB1 CACGACGATGGATTTCACCC GATGAGGCAGAGGGTGAACT Primer ID Hs.PT.5826216464
(Integrated DNA Technology)
TFF1 AGAGACATGTACAGTGGCCC GGAGGGACGTCGATGGTATT Gupta et al. 2003
S1004A GAGGGTGACAAGTTCAAGCTC GGAGGGCCCCAGCTGGCAGA Designed by Fitriya N. Dewi
GAPDH CGGATTTGGTCGTATTGG TCAAAGGTGGAGGAGTGG Tian et.al 2010
S. Mariya, et al138estrogenic treatment. The classic estrogen response marker TFF1
was expressed more prominently in MCF-12A than in MfMC,
whereas GREB1 was not expressed (see Figure 6).4. Discussion
In this study, we were able to maintain a primary culture of
M. fascicularis mammary gland cells derived from the breast tissue
collected via surgical biopsy. The cell population expressed the
epithelial cell markers CD24 and CK18, and a marker for fibroblast
S100A4. Importantly, we were able to identify the presence of stem
cells in the culture as shown by expression of various markers ofFigure 1. Cynomolgus monkey mammary gland culture predominated by epithelial-like mor
line MCF-12A is presented as morphological comparison (D).stemness. In addition, the expression of ESR1 and TFF1was positive,
indicating estrogen responsiveness of the model.
Mammary gland is an organized ductal network, wherein the
ducts comprised an inner layer of luminal epithelial cells expressing
cytokeratins such as CK18 and an outer layer of myoepithelial/basal
cells expressing other cytokeratins and a-smooth muscle actin
(Joshi et al. 2012). CK18 is also one of the established markers
typically used todelineate the degree of differentiation ofmammary
epithelial cells, as it indicates mature luminal epithelial cells (Eirew
et al., 2008). Another commonly used marker of epithelial cells is
CD24, whereby the high and low expressions of CD24 typically
correspond to luminal epithelial and myoepithelial/basal cells,
respectively (Sleeman et al.2007).MfMCgrown in our studyshowedphology on first (A), second (B), and third (C) passages. Human mammary epithelial cell
Figure 2. Viability of cells in the Macaca fascicularis mammary cell culture. Error bars¼ standard deviation.
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consistent with the fact that the culture showed a predominant
epithelial-like morphology. Importantly, this profile is comparable
with the profile of human mammary epithelial cell line MCF-12A.
Despite showing morphology of epithelial cells and being main-
tained in a medium selective for epithelial cells, the expression of a
fibroblast marker was positive in MfMC, which may indicate the
presence of stromal cell population in this model. This marker was
also expressed in MCF-12A, although in lower intensity. Mammary
gland is a heterogenous tissue, comprised epithelial cells and stro-
mal components such as adipocytes, fibroblasts, endothelial cells,
etc. (Richert et al. 2000). Further isolationwill need to be performed
to purify this model into an epithelial cell-specific cell culture
system.Figure 3. Expression of epithelial cell markers in Macaca fascicularis mammary cell
culture (MfMC). Ladder 100 bp; CK18 (137 bp), CD24 (255 bp), S1004A (280), GAPDH
(352 bp). N, MfMC; M, MCF-12A.Mammary gland stem cells are important for normal mammary
morphogenesis and tumor initiation. In the mouse model, the
currently known cell surface markers to isolate MaSCs include
CD24, CD29, and CD49f among others (Visvader 2009). The use of
these markers has been a beneficial tool to isolate and enrich
MaSCs. Moreover, cells positive for CD24 and CD29 were able to
regenerate a functional mammary gland in murine model, which
strongly supports the notion that these cells are part of a subpop-
ulation that consists of mammary gland stem cells (Shackleton et al.
2006; Stingl et al. 2006). In humans, CD49f is among the known
makers for MaSC with regenerative capacity, although the expres-
sion was also found in the epithelial luminal progenitor cells
(Visvader 2009). Here, we found that alongside the epithelialFigure 4. Expression of stem cell markers in Macaca fascicularis mammary cell culture
(MfMC). Ladder l00 bp; ITGB1 (264 bp), ITGA6 (210 bp), CD73 (101 bp), CD105 (104 bp),
GAPDH (352 bp). N, MfMC; M, MCF-12A.
Figure 5. Expression of markers for pluripotency in Macaca fascicularis mammary cell
culture (MfMC). Ladder l00 bp; NANOG (121 bp), SOX2 (151 bp), OCT4 (151 bp), GAPDH
(352 bp). N, MfMC; M, MCF-12A.
Figure 6. Expression of estrogen receptor and its activity markers in Macaca fas-
cicularis mammary cell culture (MfMC). ESR1 (241 bp), GREB1 (163 bp), TFF1 (155 bp),
GAPDH (352 bp). N, MfMC; M, MCF12A.
S. Mariya, et al140markers CD24 and CK18, the MfMC cultures were also positive for
CD29 and CD49f, suggesting that a population of MaSCs likely exists
in this primary cell culture model.
The cell culture was derived from the breast tissue of nullipa-
rous monkeys, as nulliparity is consistent with less differentiation
of the mammary gland in monkeys and humans (Cline and Wood,
2008). We have previously reported a study in monkeys that
showed terminal end bud (TEB) number was greater with less
differentiation of the breast (Dewi et al. 2013). TEB has been
thought to be the site where most MaSCs exist, as this TEB will give
rise to epithelial cells (Visvader, 2009). It is likely that choosing the
right developmental stage of the breast as tissue source is key in
gaining a culture model with ample mammary gland stem cell
population to be enriched further. Although our study indicates the
likelihood of MaSC population to be present in the cell culture
derived from nulliparous breast tissue, pubertal breast may also
serve as a good source for MaSC culture because TEBs are most
abundant in premenarchal breast (Dewi et al. 2013). Importantly, a
subset of stem cell markers including CD29 were expressed at the
highest level during puberty compared with other life stages inmonkeys (Stute et al. 2012). The use of monkey model may serve as
a highly translational source to derive a culture model enriched for
stem cells, especially from breast developmental stages that are
ethically impossible to attain in humans.
Stem cells are characterized by their ability to self-renew, which
makes them distinct from other cells. Stem cells are able to differ-
entiate into other cells that are still in its lineage (Esmailpour and
Huang, 2008). Other than adult MaSCs, in this study, we also
evaluated the expression of mesenchymal stem cells (MSCs) using
markers CD73 and CD105. These markers are typically expressed in
bone marrow and matrix umbilical cord (Hass et al. 2011) and
therefore perceived as gold-standard markers for MSCs. The
expression of these markers in MfMC primary culture is likely due
to the heterogeneity of the cell culture model. Despite using an
epithelial cell-specific media, the MSCs were possibly derived from
adipose tissue present as part of the mammary gland tissue.
Although expression of mesenchymal markers has also been
thought to be indicative of epithelialemesenchymal transition
naturally occurring in lactating breast and not of MSCs presence
(Battula et al. 2012), it is unknown if such expression in the MfMC
model is related to the multipotency of some cell population or
other epithelialemesenchymal transition-related activities.
Interestingly, pluripotent cells were reported to be present in
disease-free breast tissue of parous and nulliparous women,
whereby these cells are known to have remarkable lineage plas-
ticity (Roy et al., 2013). These cells, known as endogenous plurip-
otent somatic cells or ePS cells expressed the markers OCT3/4,
SOX2, and NANOG, were mortal and able to differentiate into
functional three lineage derivatives. Another study reported that
cells expressing the same pluripotency markers were present in
breast milk, supporting the notion that pluripotent cells are pre-
sent in normal breast (Hassiotou et al. 2012). The ePS cells are
thought to be a different subset of population from the mammary-
committed CD24CD29þCD49fþstem cells, although it was sug-
gested that such MaSC is part of the cellular hierarchy that starts at
the multilineage stem cell state (Hassiotou and Hartmann, 2014).
Here, we showed that OCT4, NANOG, and SOX2 were expressed
clearly in MfMC culture comparable with that in MCF-12A. This
finding suggests that such pluripotent cells were also present in
the monkey breast-derived cell culture model. Further studies are
needed to isolate ePS cells from MfMC and evaluate its pluripo-
tency ability. Knowledge on plasticity of stem cells, progenitor
cells, differentiated cells, and their interaction alongside the role of
stroma for cell fate programming are important to bring together
elements of biology and regulation within the mammary gland,
which can be studied further using heterogenous culture models
such as MfMC.
MfMC culture expressed ER and ER activity marker TFF1, in the
level similar to that of MCF-12A. This profile indicates that the
culture model is likely to be responsive to estrogen and estrogenic
compounds. Mammary gland is a dynamic tissue responsive to the
female reproductive hormones including estrogen. During certain
developmental windows and reproductive cycles, the population of
mammary gland stem cells are needed to expand and differentiate
into new epithelium and therefore, they must be able to respond to
the hormonal signs. As MaSCs are known to be negative for hor-
mone receptors, they require niche components to relay the hor-
monal messages to cue MaSCs programming. This role may be
served by ERþ and PRþ luminal epithelial cells as well as other
niche elements like the stromal cells (Joshi et al. 2012). The positive
expression of ESR1 in this culture model can indicate the ability of
niche cells to detect the level of circulating hormones, which are
required for MaSCs growth. In addition, TFF1 is typically used as a
marker for ER activity. However, it is also commonly used to indi-
cate the presence of oncogene in mammary gland and it may serve
Mammary gland cell culture of Macaca fascicularis 141as a beneficial information during the process of malignancy in
breast cancer (Buache et al. 2011). Our findings highlight the po-
tential use of MfMC culture model for future studies on estrogenic
compound that may be important for breast cancer prevention,
mainly those involving MaSC regulation.
The results indicate that stem cells are likely present in the
primary cell culture model derived from the cynomolgus macaque
breast. This finding suggests that MfMC may be a good source for
population of MaSCs and potentially useful for further enrichment
of stem cell population for future isolation purposes. Importantly,
the culture model shows indication of estrogen responsiveness and
mimics a heterogeneous breast tissue, which may serve as a
promising tool for in-vitro works pertaining to carcinogenesis and
cancer prevention, such as that involving estrogenic compounds
and MaSC regulation.
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